positive message20 Dec 2021 09:00
Yes, the Company has received incoming interest following the announcement.
genedrive have not provided any guidance on specific revenue timing, although you will have noted their slight delay in CE marking from around late October to early December. The Company has stated that alongside achieving CE marking, the product would be sent to interested parties for evaluation. That is seen as the first step in establishing end users and intermediary distribution partners. Products have been sent and discussions are ongoing. End users of clinical product often have specific local verification and validation processes (users are normally accredited and regulated, unlike consumer products) that they need to go though.